|
?:authorAffiliation
|
-
[\'Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.\', \'ICES, Toronto, Ontario, Canada.\', \'Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.\', \'School of Public Health, University of Alberta, Edmonton, Alberta, Canada.\', \'Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.\', \'Department of Medicine, McMaster University, Hamilton, Ontario, Canada.\', \'Division of Neurology, The University of British Columbia, Vancouver, Columbia, Canada.\', \'Stanford Stroke Center, Palo Alto, California, USA.\', \'Immunization and vaccine-preventable diseases, Public Health Ontario, Toronto, Ontario, Canada.\', \'Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada jeff.kwong@utoronto.ca.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}